At 11:00 am on June 6, the Information Office of the Municipal Government held a press conference to introduce the relevant situation of "Several Measures to Support the high-quality Development of Innovative Medicine in Jinan City (2024)" (hereinafter referred to as "several measures"), and answered questions from reporters.
Xu Lei, a member of the Party group and deputy director of Jinan Bureau of Industry and Information Technology, introduced that biomedicine and great health industry is one of the four leading pillar industries focused on the development of the city. In recent years, the Municipal Bureau of Industry and Information Technology has focused on the five fields of biomedicine, traditional Chinese medicine, medical devices, medical beauty anti-aging, and special medical food, forming a relatively complete industrial chain group from basic research, clinical trials, manufacturing, sales and service to medical health care, mainly with the following five aspects of characteristics and advantages.
First, it has cultivated a group of leading enterprises with strong influence and driving force. It has a group of leading backbone enterprises such as Qilu Pharmaceutical, Huaxi Biological, Boke Holding, Freida Biological, Hongjitang, Yinfeng Biological and so on. Among them: Qilu Pharmaceutical ranks fifth in the national Top 100 pharmaceutical industry, Huaxi Biological is the world's largest hyaluronic acid production and research and development enterprises, hyaluronic acid global market share of more than 40%.
Second, it has created a number of high-level R&D and innovation platforms. It has built 12 national R&D platforms, 219 provincial innovation platforms, and 87 municipal key laboratories. Innovative products leading domestic, with Shandong Shennoki. Icariin raw material, Qilu Pharmaceutical. Iruak tablets 2 class 1 innovative drugs. The city has a total of 1333 drug approval numbers, 1397 Class 2 and Class 3 medical device approvals, 279 drugs through consistency evaluation, ranking first in Shandong Province.
Third, it has a number of core advantage products with strong market competitiveness. The global market share of more than 20 raw materials such as cephalosporin and batan series is the first; The international market share of 22 preparation products is the first, and the domestic market share of more than 60 preparation products is the first. Our city has 73 of the country's first or exclusive listed products, biosimilar drugs. Bevacizumab took the lead in realizing industrialization in China.
Fourth, is to form a spatial layout of "double core, double valley and multiple gardens". The industrial layout has been accelerated and optimized, forming a development pattern led by the "dual core" of Jinan High-tech Zone and Jinan International Medical Center, supported by the "double valley" of the world's hyaluronic acid Valley and the "double Valley" of Luzhong International Biological Valley, and the "multi-park" development of key parks such as Qilu Pharmaceutical Biomedical Industrial Park. With 7 industrial clusters above the provincial level, Jinan takes the pharmaceutical manufacturing industry as a characteristic and advantageous industry, and has been awarded the "three products" strategy demonstration city of the Ministry of Industry and Information Technology.
Fifth, the industrial ecology enriched in resource elements. The city has 17 medical colleges and universities, 28 national key disciplines and clinical key disciplines, and 30 drug clinical trial bases, providing surging momentum for industrial innovation and development. Lead the establishment of the provincial capital economic circle biomedical industry alliance, deepen the industrial division of labor and cooperation, and promote the coordinated development of the provincial capital economic circle biomedical and large health industry.
In the next step, the Municipal Bureau of Industry and Information Technology will solidly promote the key tasks of the "Several Measures to support the high-quality development of innovative Medicine in Jinan", pay close attention to the forefront of industrial development, accelerate the innovation and development of the medical and health industry, accelerate the cultivation and development of new quality productivity, and strive to create five characteristic industrial chain groups. First, in the field of biological drugs and chemicals, we focus on the development of biological drugs and high-end new preparations such as antibody drugs, recombinant protein and peptide drugs, nucleic acids, genes and cells, and accelerate the pace of new drug innovation and development and industrialization. Second, in the field of traditional Chinese medicine, accelerate the research and development of new Chinese medicine drugs, optimize and improve the industrial model of "smart traditional Chinese medicine pharmacy". Third, in the field of medical devices, we will increase the research and development of high-performance medical polymer products, orthopedic repair and implant materials and devices. Fourth, in the field of medical and anti-aging, accelerate the industrialization of six functional raw materials such as functional sugars, proteins and peptides, and gradually improve the product matrix of high-end cosmetics and medical and beauty medical devices. The fifth is the field of special medical food, focusing on promoting the formation of a diversified product system dominated by special medical food, supplemented by elderly food, sports food, health (functional) food, and key functional raw material manufacturing.
Source of the above content: Love Jinan news client, if there is infringement contact delete.
